Resorantel: a dual-targeting therapeutic with potent efficacy against Staphylococcus aureus with low potential for drug resistance
Authors:
Open Access
- 2 July 2026
- journal article
- research article
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a significant public health concern. The biofilm formation capability of MRSA is often associated with high levels of antimicrobial resistance. Therefore, the development of novel therapeutic strategies to combat MRSA is urgently warranted. By drug repurposing, resorantel, originally developed as an antiparasitic agent, has demonstrated significantly bactericidal activity against MRSA and its biofilms with effectively inhibitory activity against the emergence of drug resistance. Furthermore, resorantel displayed significant in vivo antibacterial efficacy in both topic and systemic infection models. Mechanistic investigations employing transcriptomics, fluorescent probes, molecular dynamics simulations, and surface plasmon resonance analysis revealed that proton motive force and MurB are likely the potential targets of resorantel. Collectively, this study identifies resorantel as a promising novel antimicrobial agent with potential for use in the treatment of MRSA and its biofilm-related infections.Keywords
This publication has 45 references indexed in Scilit:
- Novel antibiotics against Staphylococcus aureus without detectable resistance by targeting proton motive force and FtsHMedcomm, 2025
- Structure-guided identification of potential inhibitors of MurB from S. typhimurium LT2 strain: towards therapeutic development against multidrug resistanceMolecular Diversity, 2024
- Daptomycin: Mechanism of action, mechanisms of resistance, synthesis and structure-activity relationships2024
- Bacterial proton motive force as an unprecedented target to control antimicrobial resistanceMedicinal Research Reviews, 2023
- Novel bis(pyrazole-benzofuran) hybrids possessing piperazine linker: Synthesis of potent bacterial biofilm and MurB inhibitorsBioorganic Chemistry, 2020
- A Deep Learning Approach to Antibiotic DiscoveryCell, 2020
- Molecular mechanisms of vancomycin resistanceProtein Science, 2020
- A Biosurfactant‐Inspired Heptapeptide with Improved Specificity to Kill MRSAAngewandte Chemie International Edition, 2017
- Inhibitors of the peptidoglycan biosynthesis enzymes MurA-FBioorganic Chemistry, 2014
- Efficacy of resorantel against paramphistomiasis in naturally infected sheepTropical Animal Health and Production, 1981